An Institut Pasteur team has successfully developed a pentavalent vaccine against the five pathogenic arenaviruses circulating in South America and tested it in a primate model. Each of the viruses has a low incidence but a very high mortality rate, so combining them in a single vaccine would help facilitate vaccine development and ensure that the population can be protected as soon as possible.

Find out more